Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial.

PubWeight™: 2.18‹?› | Rank: Top 2%

🔗 View Article (PMID 6341842)

Published in N Engl J Med on June 02, 1983

Authors

F Khaja, J A Walton, J F Brymer, E Lo, L Osterberger, W W O'Neill, H T Colfer, R Weiss, T Lee, T Kurian, A D Goldberg, B Pitt, S Goldstein

Articles citing this

The end of clinical freedom. Br Med J (Clin Res Ed) (1983) 6.27

Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex. Br Med J (Clin Res Ed) (1986) 2.33

Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart. Am J Pathol (1990) 0.98

What proportion of patients with myocardial infarction are suitable for thrombolysis? Br Heart J (1987) 0.92

Intracoronary thrombolysis in acute myocardial infarction. Br Heart J (1983) 0.89

Reduction of infarct size. An attractive concept: useful--or possible--in humans? Br Heart J (1985) 0.87

High dose intravenous streptokinase in acute myocardial infarction--short and long term prognosis. Br Heart J (1986) 0.86

Long term improvement in global left ventricular function after early thrombolytic treatment in acute myocardial infarction. Report of a randomised multicentre trial of intracoronary streptokinase in acute myocardial infarction. Br Heart J (1986) 0.81

Prediction of spontaneous coronary reperfusion in myocardial infarction. Postgrad Med J (1986) 0.79

Is thrombolysis alone the best therapy for acute myocardial infarction? Current status and emerging strategies. Tex Heart Inst J (1991) 0.76

Myocardial protection during surgical intervention for treatment of acute myocardial infarction. Tex Heart Inst J (1992) 0.75

Holter monitoring of ventricular arrhythmias in a randomised, controlled study of intravenous streptokinase in acute myocardial infarction. Br Heart J (1991) 0.75

Intravenous short-term infusion of streptokinase in acute myocardial infarction. Tex Heart Inst J (1984) 0.75

Anticoagulant therapy. Can Fam Physician (1984) 0.75

Coronary thrombolysis with tissue-type plasminogen activator: prospective review. Tex Heart Inst J (1984) 0.75

After thrombolytic therapy: angiography, angioplasty, or surgery? Tex Heart Inst J (1990) 0.75

Back to the future: so what will fibrinolytic therapy offer your patients with myocardial infarction? Br Med J (Clin Res Ed) (1986) 0.75

Recent clinical developments in thrombolysis in acute myocardial infarction. Drugs (1987) 0.75

Acute coronary occlusion and reperfusion. Reliability of angiographic classification and grading. Drugs (1987) 0.75

Articles by these authors

A contribution to the physiology of the spleen. J Physiol (1925) 17.47

Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res (2000) 10.78

Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A (1992) 10.19

Health science information management and continuing education of physicians. A survey of U.S. primary care practitioners and their opinion leaders. Ann Intern Med (1989) 9.87

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors. N Engl J Med (1992) 8.38

A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell (1990) 8.10

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet (1992) 7.22

Promising protein for Parkinson's. Science (1993) 6.51

The influence of the spleen in carbon monoxide poisoning. J Physiol (1925) 5.90

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA (2000) 5.49

Single-chain antigen-binding proteins. Science (1988) 5.29

Increased bone formation in osteocalcin-deficient mice. Nature (1996) 4.91

ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol (2001) 4.89

Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med (1997) 4.88

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet (1996) 4.61

Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med (1999) 4.37

Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J Virol (1996) 4.29

The on-call experience of interns in internal medicine. Medical Education Task Force of Henry Ford Hospital. Arch Intern Med (1990) 4.26

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation (2001) 4.24

Role of phosphorylation in p34cdc2 activation: identification of an activating kinase. Mol Biol Cell (1992) 4.17

Cardiologist versus internist management of patients with unstable angina: treatment patterns and outcomes. J Am Coll Cardiol (1995) 4.10

Management of heart failure. I. Pharmacologic treatment. JAMA (1994) 4.07

Laser capture microdissection: molecular analysis of tissue. Science (1997) 3.93

Plant diversity enhances ecosystem responses to elevated CO2 and nitrogen deposition. Nature (2001) 3.92

The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J Virol (1997) 3.77

Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med (2000) 3.70

The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell (1990) 3.56

Transplantation of cultured human neuronal cells for patients with stroke. Neurology (2000) 3.38

Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking alpha(1G) T-type Ca(2+) channels. Neuron (2001) 3.37

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A (2000) 3.34

"Atypical" depression following childbirth. Br J Psychiatry (1968) 3.32

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation (1996) 3.28

Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Investigators. Arch Intern Med (2000) 3.25

Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification. Nat Med (1998) 3.19

Age-related changes in oxidized proteins. J Biol Chem (1987) 3.18

A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res (2010) 3.15

Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science (1975) 3.12

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med (1987) 3.04

X-linked ichthyosis due to steroid-sulphatase deficiency. Lancet (1978) 3.00

Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication. J Virol (1995) 2.96

Iatrogenic coronary artery dissections extending into and involving the aortic root. Catheter Cardiovasc Interv (2000) 2.94

Psychological factors related to prehospital delay during acute myocardial infarction. Circulation (1991) 2.88

Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature (1976) 2.85

Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med (1999) 2.84

Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet (1998) 2.84

The effect of ethnicity on physician estimates of pain severity in patients with isolated extremity trauma. JAMA (1994) 2.77

Thallium-201 for myocardial imaging. Relation of thallium-201 to regional myocardial perfusion. Circulation (1975) 2.77

Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet (1995) 2.74

Non-inactivation of an x-chromosome locus in man. Science (1979) 2.74

Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Early Management of Patients with Acute Myocardial Infarction) J Am Coll Cardiol (1990) 2.70

The Pumilio RNA-binding domain is also a translational regulator. Mol Cell (1998) 2.68

Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med (1997) 2.65

Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV. J Virol (2000) 2.65

Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med (1999) 2.63

Crystal structure of yeast tRNAAsp. Nature (1980) 2.61

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation (1994) 2.61

Thermodynamic analysis of the folding of the streptococcal protein G IgG-binding domains B1 and B2: why small proteins tend to have high denaturation temperatures. Biochemistry (1992) 2.56

Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nat Med (1997) 2.47

A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3. J Virol (1997) 2.46

Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation (2001) 2.43

Genomic imprinting in an Angelman and Prader-Willi translocation family. Lancet (1991) 2.41

Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox. J Cell Biol (2001) 2.40

Different functions for the thyroid hormone receptors TRalpha and TRbeta in the control of thyroid hormone production and post-natal development. EMBO J (1999) 2.27

A critical appraisal of milieu therapy in a geriatric day hospital. J Am Geriatr Soc (1971) 2.27

Thallium-201 myocardial perfusion imaging at rest and during exercise. Comparative sensitivity to electrocardiography in coronary artery disease. Circulation (1977) 2.22

BASDEC: a novel screening instrument for depression in elderly medical inpatients. BMJ (1992) 2.21

Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med (1999) 2.19

Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol (1992) 2.18

The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques. Virology (1991) 2.15

Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation (2000) 2.15

The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study. Cardiovasc Drugs Ther (2001) 2.13

Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration. J Am Coll Cardiol (2000) 2.12

Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med (1998) 2.12

Reye's syndrome: a case control study of medication use and associated viruses in Australia. Cleve Clin J Med (1990) 2.11

A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol (1991) 2.08

Water magnetic relaxation dispersion in biological systems: the contribution of proton exchange and implications for the noninvasive detection of cartilage degradation. Proc Natl Acad Sci U S A (2001) 2.07

A noninvasive scintiphotographic method for detecting regional ventricular dysfunction in man. N Engl J Med (1971) 2.05

Effect of ischemia and antianginal drugs on the distribution of radioactive microspheres in the canine left ventricle. Circ Res (1971) 2.05

Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation (1997) 2.04

Mindwandering and cognitive structure. Trans N Y Acad Sci (1970) 2.03

Oral flecainide acetate for the treatment of ventricular arrhythmias. N Engl J Med (1981) 1.99

Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res (2010) 1.99

A persistent untranslated sequence within bacteriophage T4 DNA topoisomerase gene 60. Science (1988) 1.99

Impact of inter-physician communication on the effectiveness of medical consultations. Am J Med (1983) 1.98

Mechanism of ribosome frameshifting during translation of the genetic code. Nature (1983) 1.95

Variability of DNA methylation patterns during serial passage of human diploid fibroblasts. Proc Natl Acad Sci U S A (1982) 1.95

Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial. Am J Cardiol (1990) 1.94

Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev (2006) 1.93

Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction. Circulation (1980) 1.88

A simple and sensitive antigen retrieval method for free-floating and slide-mounted tissue sections. J Neurosci Methods (1999) 1.84

Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab (1995) 1.84

Characterization of Torpedo californica acetylcholine receptor: its subunit composition and ligand-binding properties. Cold Spring Harb Symp Quant Biol (1976) 1.81

Diabetes mellitus and aging: diminished planting efficiency of cultured human fibroblasts. Proc Natl Acad Sci U S A (1969) 1.78

Delay in hospitalization during the acute coronary period. Am J Cardiol (1969) 1.77

A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J Lipid Res (1981) 1.77

Sudden death in the year following myocardial infarction. Relation to ventricular premature contractions in the late hospitals phase and left ventricular ejection fraction. Am J Med (1977) 1.77

Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothin. Antimicrob Agents Chemother (1974) 1.76

Paradoxical use of a demand pacemaker in treatment of supraventricular tachycardia due to the Wolff-Parkinson-White syndrome. Observation on termination of reciprocal rhythm. Circulation (1968) 1.75